You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD8 T cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Memory CD8+ T Cells With Sepsis Severity and

Recruiting
  • Sepsis
  • Inflammatory Response
    • Wuhan, Hubei, China
      Department of Critical Care Medicine, Union Hospital, Tongji Med
    May 16, 2023

    NSCLC, Small Cell Lung Cancer, Pancreas Cancer Trial in Shanghai (Infusion of iNKT cells and CD8+T cells)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • +5 more
    • Infusion of iNKT cells and CD8+T cells
    • Shanghai, Shanghai, China
      Shanghai Public Health Clinical Center
    May 6, 2022

    SARS-CoV-2 Specific CD8 T Cells in Humans

    Recruiting
    • COVID-19
      • Baltimore, Maryland
        National Institute of Aging, Clinical Research Unit
      Jul 6, 2022

      Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

      Completed
      Has Results
      • Recurrent Plasma Cell Myeloma
      • Refractory Plasma Cell Myeloma
      • Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
      • +3 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Aug 3, 2022

      Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • +4 more
      • (no location specified)
      Oct 23, 2023

      Multiple Myeloma Trial in Bethesda, Oklahoma City, Fairfax (Descartes-08, Fludarabine, Cyclophosphamide)

      Completed
      • Multiple Myeloma
      • Descartes-08
      • +2 more
      • Bethesda, Maryland
      • +2 more
      Mar 10, 2022

      CD8+ T-cell PET/CT Imaging in COVID-19 Patients

      Recruiting
      • Lymphopenia Due to COVID-19
      • +2 more
      • [89Zr]Df-IAB22M2C PET/CT scan
      • Nijmegen, Gelderland, Netherlands
        Radboud university medical center
      Jun 2, 2022

      Healthy, Cytotoxicity, Yellow Fever Vaccination Reaction Trial in Aarhus (Yellow Fever Vaccine)

      Unknown status
      • Healthy
      • +2 more
      • Yellow Fever Vaccine
      • Aarhus, Denmark
        Aarhus University Hospital
      Oct 28, 2021

      IL-17+ CD8 T Cells in Cancer Patients Trial in Taichung

      Completed
      • IL-17+ CD8 T Cells in Cancer Patients
        • Taichung, Taiwan
          China Medical University Hospital
        Jul 27, 2021

        COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

        Active, not recruiting
        • COL6A3 Positive
        • +3 more
        • Aldesleukin
        • +4 more
        • Houston, Texas
          M D Anderson Cancer Center
        Sep 22, 2022

        HIV Trial in Sacramento, San Francisco (drug, biological, other)

        Recruiting
        • HIV Infections
        • Sacramento, California
        • +1 more
        May 17, 2022

        Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

        Not yet recruiting
        • Metastatic Colorectal Adenocarcinoma
        • +5 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Sep 12, 2023

        Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

        Suspended
        • Juvenile Myelomonocytic Leukemia
        • +27 more
        • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
        • +2 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Jan 11, 2023

        Advanced Solid Tumors Trial in Belgium, Germany, Spain (Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR)

        Recruiting
        • Advanced Solid Tumors
        • Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR
        • Ghent, Belgium
        • +2 more
        Jun 23, 2022

        Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present Trial in Seattle (Aldesleukin,

        Terminated
        Has Results
        • Acute Myeloid Leukemia
        • +4 more
        • Aldesleukin
        • +2 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Oct 15, 2021

        Acute Myeloid Leukemia Trial in Ramat Gan (CAR-T CD19)

        Recruiting
        • Acute Myeloid Leukemia
        • CAR-T CD19
        • Ramat Gan, Israel
          Chaim Sheba Medical Center
        Oct 30, 2022

        HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

        Recruiting
        • HNSCC
        • +5 more
        • DP CD8 TIL
        • +2 more
        • Portland, Oregon
          Providence Portland Medical Center
        Jun 5, 2023

        Glioblastoma Trial in Gainesville (Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells)

        Not yet recruiting
        • Glioblastoma
        • Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells
        • Gainesville, Florida
          University of Florida Health
        Jul 29, 2022

        Innate CD8+ T Cells and Evolution of Tyrosine Kinase Inhibitor

        Recruiting
        • Leukemia
        • +3 more
        • Phenotyping of total and innate CD8+T cells by flow cytometry
        • Nîmes, Gard, France
          CHU de Nîmes
        Jul 19, 2021

        Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

        Active, not recruiting
        • Metastatic Malignant Neoplasm in the Liver
        • Metastatic Uveal Melanoma
        • Aldesleukin
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 20, 2023

        Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte

        Not yet recruiting
        • Castration-Resistant Prostate Carcinoma
        • +2 more
        • Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
        • +7 more
        • Duarte, California
          City of Hope Medical Center
        Apr 5, 2023

        Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL) Trial in Milwaukee (8/12-Day

        Recruiting
        • Non Hodgkin Lymphoma (NHL)
        • +6 more
        • 8/12-Day Production of Car-T Cells
        • +2 more
        • Milwaukee, Wisconsin
          Medical College of Wisconsin and Froedtert Hospital
        Jul 1, 2022

        Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Solid Tumor Trial in

        Suspended
        • Anatomic Stage IV Breast Cancer AJCC v8
        • +8 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        May 23, 2022

        HPV 16+ Recurrent or Metastatic Cancer Trial (CD8 reduced peripheral blood cells taken from related donors vaccinated against

        Not yet recruiting
        • HPV 16+ Recurrent or Metastatic Cancer
        • CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16
        • Non-myeloablative allogeneic bone marrow transplant from related donors vaccinated against HPV16
        • (no location specified)
        Jun 27, 2022

        Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

        Recruiting
        • Benign Lymphoproliferative Disorder
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Feb 2, 2023